NCT02366637 - An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Placebo

Orally inhaled placebo twice a day (BID) for 4 weeks

DRUG

PF-03715455

680 micrograms BID, Orally inhaled PF-03715455 for 4 weeks

Trial Locations (5)

Medicines Evaluation Unit Ltd, Wythenshawe

Nottingham University Hospital NHS Trust, Nottingham

University Hospitals Birmingham NHS Foundation Trust, Birmingham

Heart of England NHS Foundation Trust, Birmingham

Respiratory Medicine, Bradford Institute of Health Research, Bradford